TABLE 4.
Parameters | Days | Treatments* | ||||
---|---|---|---|---|---|---|
Control | GP5 | GP10 | GP15 | GP20 | ||
RBC (×106 mm3−1) | 60 | 1.4 ± 0.1bc | 1.4 ± 0.1bc | 1.6 ± 0.1ab | 1.8 ± 0.1a | 1.2 ± 0.1c |
120 | 1.7 ± 0.1b | 1.5 ± 0.1b | 1.6 ± 0.1b | 2.3 ± 0.1a | 1.7 ± 0.1b | |
WBC (×104 mm3−1) | 60 | 5.2 ± 0.2b | 6.4 ± 0.2a | 5.7 ± 0.2b | 7.0 ± 0.3a | 5.1 ± 0.1b |
120 | 5.7 ± 0.1c | 6.8 ± 0.1b | 5.9 ± 0.2c | 8.5 ± 0.3a | 5.6 ± 0.1c | |
Hb (g%) | 60 | 7.9 ± 0.2ab | 8.0 ± 0.1a | 7.9 ± 0.2ab | 8.3 ± 0.1a | 7.5 ± 0.1b |
120 | 8.1 ± 0.3b | 8.3 ± 0.1b | 8.4 ± 0.3b | 10.3 ± 0.5a | 7.9 ± 0.1b | |
Ht/PCV (%) | 60 | 19.2 ± 0.5b | 33.8 ± 3.2a | 27.4 ± 1.6a | 28.1 ± 0.8a | 20.0 ± 1.0b |
120 | 23.3 ± 1.0c | 32.8 ± 1.1b | 33.3 ± 1.9b | 41.1 ± 0.5a | 21.6 ± 1.0c | |
MCV (μ·m3) | 60 | 133.1 ± 3.9b | 246.8 ± 19.3a | 172.7 ± 14.0b | 154.4 ± 10.6b | 167.9 ± 19.4b |
120 | 138.1 ± 5.9c | 216.1 ± 1.3a | 202.4 ± 6.3ab | 178.4 ± 11.3b | 128.7 ± 9.8c | |
MCH (g%) | 60 | 54.6 ± 4.7ab | 59.2 ± 3.9a | 50.0 ± 3.0ab | 45.8 ± 2.7b | 62.3 ± 4.2a |
120 | 48.3 ± 3.7ab | 54.8 ± 2.4a | 51.4 ± 1.1ab | 44.6 ± 2.8b | 46.8 ± 1.6ab | |
MCHC (%) | 60 | 40.9 ± 2.3a | 24.3 ± 2.6b | 29.1 ± 1.4b | 29.7 ± 0.5b | 37.6 ± 2.1a |
120 | 35.0 ± 2.6a | 25.4 ± 1.1b | 25.4 ± 0.4b | 25.1 ± 1.6b | 36.6 ± 1.5a |
These are significant differences among the treatments in a row.